Director, Women's Cancer Program at the Samuel Oschin Cancer Institute at Cedars Sinai Medical Cente

Obstetrics & Gynecology

Beth Y. Karlan works in the field of Obstetrics & Gynecology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"10 Women Leaders Who Impact LA", "Nominated for the PROSE Award (Gynecologic Oncology: Clinical Practice & Surgical Atlas)", "Professorship", "Honoree", "Selected to attend Harvard Physician Leadership in Academic Medicine Program", "M.D. Prize for Excellence in Ovarian Cancer Research", "Early Detection Professorship", "America's Top Doctors for Cancer", "Public Service Award", "Women of Distinction, Hadassah", "Mother of the Year", "Nat King Cole Research Award (Research for Women's Cancers)", "Award for Excellence", "Board of Governors' Endowed Chair in Gynecologic Oncology", "James F. Nolan Award", "Richard F. Dwyer-Eleanor W. Dwyer Award for Excellence", "Scholar Award", "Clinical Oncology Career Development Award", "J. G. Moore Award", "Meehan-Miller Award", "James Hudson Brown/Alexander B. Coxe Fellowship", "ACOG-Ortho Academic Training Fellowship in Obstetrics and Gynecology", "Super Doctor", "Fellow (FACOG)", "Whos Who in Medicine and Healthcare", "Fellow (FACS)" and "Top MD". Beth Karlan is also published. He has 32 publications published. The lastest publication: "Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.' He accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Digoxin therapy is not associated with improved survival in epithelial ovarian Cancer: A SEER-Medicare database analysis.
• Common variants at the CHEK2 gene locus and risk of epithelial ovarian Cancer.
• Identifying post-menopausal women at elevated risk for epithelial ovarian Cancer.
• Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
• Rethinking ovarian Cancer II: reducing mortality from high-grade serous ovarian Cancer.
• Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.
• FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer.
• Evaluating the ovarian Cancer gonadotropin hypothesis: A candidate gene study.
• Clinicopathological analysis of endometrial Carcinomas harboring somatic POLE exonuclease domain mutations.
• Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers.
• BRCA1 germline mutations may be associated with reduced Ovarian reserve.
• A cautious view of putative precursors of serous Carcinomas in the fallopian tubes of BRCA mutation carriers.
• ABCA transporter gene expression and poor outcome in epithelial ovarian Cancer.
• Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian Cancer outcome.
• A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer.
• Thrombocytosis at secondary cytoreduction for recurrent ovarian Cancer predicts suboptimal resection and poor survival.
• POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian Cancer.
• Post Treatment Surveillance of Type II Endometrial Cancer Patients.
• Venous thromboembolism during primary treatment of ovarian clear cell Carcinoma is associated with decreased survival.
• Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis.
• Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.
• YAP modifies Cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.
• Genomic and functional characterizations of phosphodiesterase subtype 4D in human Cancers.
• Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
• Obesity-associated adipokines correlate with survival in epithelial ovarian Cancer.
• Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.
• A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission.
• Biopsychological Stress Factors in BRCA Mutation Carriers.
• Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System.
• Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.
• Characteristics of 10-year survivors of high-grade serous ovarian Carcinoma.

Schools

---

• Harvard Medical School

• Yale New Haven Hospital

• UCLA Med School

Procedures Preformed

---

• Excision of Cervix
• Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
• Gynecologic Cancer Screening
• Hysterectomy - Laparoscopic
• View All

Conditions Treated

---

• Asymptomatic Post-Menopausal Status
• Atrophic Vaginitis
• Carcinoma in Situ
• Cervical Cancer
• View All

Doctors Specialties

---

• Gynecologic Oncology
• Obstetrics
• Gynecology

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Blue Card PPO
• CaliforniaCare HMO
• Advantage Preferred DirectAccess Plus PPO
• Blue Cross Blue Shield of California PPO
• Pathway X Direct Access PPO
• Pathway X Tiered Direct Access
• Select Plus HMO
• Access Plus Savenet
• Basic PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• Coventry Health Care
• Delta Health System
• First Health (Coventry Health Care) PPO
• Covered California - Bronze PPO
• Employer Group HMO
• Health Net PPO
• Individual and Family PPO
• Medicare MCR
• Kaiser PHCS Network PPO
• MultiPlan PPO
• PHCS Network PPO
• Heritage Signature
• Principal Life
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• PacifiCare HMO
• United Healthcare

Awards

---

• 10 Women Leaders Who Impact LA
• Nominated for the PROSE Award (Gynecologic Oncology: Clinical Practice & Surgical Atlas)
• Professorship
• Honoree
• Selected to attend Harvard Physician Leadership in Academic Medicine Program
• M.D. Prize for Excellence in Ovarian Cancer Research
• Early Detection Professorship
• America's Top Doctors for Cancer
• Public Service Award
• Women of Distinction, Hadassah
• Mother of the Year
• Nat King Cole Research Award (Research for Women's Cancers)
• Award for Excellence
• Board of Governors' Endowed Chair in Gynecologic Oncology
• James F. Nolan Award
• Richard F. Dwyer-Eleanor W. Dwyer Award for Excellence
• Scholar Award
• Clinical Oncology Career Development Award
• J. G. Moore Award
• Meehan-Miller Award
• James Hudson Brown/Alexander B. Coxe Fellowship
• ACOG-Ortho Academic Training Fellowship in Obstetrics and Gynecology
• Super Doctor
• Fellow (FACOG)
• Whos Who in Medicine and Healthcare
• Fellow (FACS)
• Top MD

Education

---

• Yale-New Haven Hospital
• Harvard Medical School

Hospital

---

• Ronald Reagan UCLA Medical Center
• Cedars-Sinai Medical Center

Drug Facts

---

NPI NUMBER		1609859586
NPPES Provider LastName		KARLAN
NPPES Provider FirstName		BETH
NPPES Provider ZIPCode		900481865
NPPES Provider State		CA
Specialty Description		Obstetrics/Gynecology
Total Claim Count		125.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1609859586
Last Name Of The Provider	KARLAN
First Name Of The Provider	BETH
View All

Similar Doctors

---

	Dr. George S. Weinberger, MD This Doctor is OpenDoctor Recommended.
	Dr. Dolores R. Kent, MD This Doctor is OpenDoctor Recommended.
	Dr. Christine S. Walsh, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew J. Li, MD This Doctor is OpenDoctor Recommended.
	Dr. Jessica L. Schneider, MD This Doctor is OpenDoctor Recommended.
	Dr. Ilana Cass, MD This Doctor is OpenDoctor Recommended.
	Dr. Jane L. Davis, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog